Early research (Phase 1)Study completedNCT03301090
What this trial is testing
A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051
Who this might be right for
Corona Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 48